These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 371974)

  • 41. Effects of two oral iron preparations on results of the benzidine test for occult blood in stools.
    Cumming JD; Percival HG
    J Clin Pathol; 1968 Jan; 21(1):41-3. PubMed ID: 4880407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An improved, highly sensitive method for the determination of serum iron using chromazurol B.
    Tabacco A; Moda E; Tarli P; Neri P
    Clin Chim Acta; 1981 Aug; 114(2-3):287-90. PubMed ID: 7285354
    [No Abstract]   [Full Text] [Related]  

  • 43. Application of Fe+2-5-pyridyl-benzodiazepin-2-ones to the automated determinations of serum iron and iron-binding capacity.
    Klein B; Kleinman N; Searcy RL
    Clin Chem; 1970 Jun; 16(6):495-9. PubMed ID: 5427532
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of chelation and binding equilibria in iron metabolism.
    CHARLEY P; ROSENSTEIN M; SHORE E; SALTMAN P
    Arch Biochem Biophys; 1960 Jun; 88():222-6. PubMed ID: 13809325
    [No Abstract]   [Full Text] [Related]  

  • 45. The Puzzle of Aspirin and Iron Deficiency: The Vital Missing Link of the Iron-Chelating Metabolites.
    Kontoghiorghes GJ
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs.
    Kontoghiorghes GJ
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequency of sensory neural hearing loss in major Beta-thalassemias in southern iran.
    Faramarzi A; Karimi M; Heydari ST; Shishegar M; Kaviani M
    Iran J Pediatr; 2010 Sep; 20(3):308-12. PubMed ID: 23056722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thalassemia in Vietnamese refugees.
    Chaytors RG; Woolgar MJ
    Can Med Assoc J; 1981 May; 124(10):1266-7. PubMed ID: 7237314
    [No Abstract]   [Full Text] [Related]  

  • 49. A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine.
    Moayedi B; Gharagozloo M; Esmaeil N; Maracy MR; Hoorfar H; Jalaeikar M
    Eur J Haematol; 2013 Mar; 90(3):202-9. PubMed ID: 23278124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.
    Gharagozloo M; Moayedi B; Zakerinia M; Hamidi M; Karimi M; Maracy M; Amirghofran Z
    Fundam Clin Pharmacol; 2009 Jun; 23(3):359-65. PubMed ID: 19453758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Evaluation of iron overload in thalassemia].
    Piga A; Davico S; Magliano M; Luzzatto L; Sandri A; Gabutti V
    Pediatr Med Chir; 1986; 8(1):9-13. PubMed ID: 3725619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
    Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chelation therapy in beta-thalassemia major: a one-year double blind study of 2,3-dihydroxybenzoic acid.
    Peterson CM; Graziano JH; Grady RW; Jones RL; Markenson A; Lavi U; Canale V; Gray GF; Cerami A; Miller DR
    Exp Hematol; 1979 Feb; 7(2):74-80. PubMed ID: 371974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
    Giardina PJ; Grady RW
    Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.